• OPEN AN ACCOUNT
Indian Indices
Sensex
74,529.08 -329.91
( -0.44%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,723.15 -15.86
(-0.15%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
47.15
1165.2
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.05
 

Arihant Superstructures consolidated net profit rises 5.68% in the March 2026 quarter
May 16,2026
Net profit of Arihant Superstructures rose 5.68% to Rs 11.91 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025. Sales rose 18.50% to Rs 180.80 crore in the quarter ended March 2026 as against Rs 152.58 crore during the previous quarter ended March 2025.

For the full year,net profit declined 15.80% to Rs 46.04 crore in the year ended March 2026 as against Rs 54.68 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 550.97 crore in the year ended March 2026 as against Rs 498.83 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales180.80152.58 18 550.97498.83 10
OPM %16.7214.41 -22.9720.97 -
PBDT16.1310.76 50 63.9168.56 -7
PBT15.4010.11 52 61.0866.19 -8
NP11.9111.27 6 46.0454.68 -16